阿瓦诺斯医疗公司2025年季度报告

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period endedSeptember 30, 2025OR☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________Commission File Number001-36440 AVANOS MEDICAL, INC. (Exact name of registrant as specified in its charter) 46-4987888 (I.R.S. Employer Identification No.) 5405 Windward ParkwaySuite 100 SouthAlpharetta,Georgia30004(Address of principal executive offices)(Zip code) Registrant’s telephone number, including area code:(844)428-2667 Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)hasbeen subject to such filing requirements for the past 90days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant wasrequired to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reportingcompany. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growthcompany” in Rule 12b-2 of the Exchange Act. Large accelerated filer☒Non-accelerated filer☐Smallerreportingcompany☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). As of October29, 2025, there were46,418,907shares of the registrant’s common stock outstanding. Table of Contents PART I – FINANCIAL INFORMATIONItem 1. Financial Statements4Unaudited Condensed Consolidated Income Statements for the Three andNineMonths EndedSeptember30, 2025 and20244Unaudited Condensed Consolidated Statements of Comprehensive Income for the Three andNineMonths EndedSeptember30, 2025 and 20245Unaudited Condensed Consolidated Balance Sheets as ofSeptember30, 2025 and December 31, 20246Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the Three andNineMonths EndedSeptember30, 2025 and 20247Unaudited Condensed Consolidated Cash Flow Statements for theNineMonths EndedSeptember30, 2025 and 20248Notes to the Unaudited Condensed Consolidated Financial Statements9Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations25Item 3. Quantitative and Qualitative Disclosures About Market Risk33Item 4. Controls and Procedures33PART II – OTHER INFORMATION34Item1. Legal Proceedings34Item1A. Risk Factors34Item 2. Unregistered Sales of Equity Securities and Use of Proceeds35Item 3. Defaults Upon Senior Securities35Item 4. Mine Safety Disclosures35Item 5. Other Information35Item6. Exhibits36Signatures37 Information Concerning Forward-Looking Statements This Quarterly Report on Form 10-Q (this “Form 10-Q”) contains “forward-looking statements” within the meaning of the PrivateSecurities Litigation Reform Act of 1995. These forward-looking statements are included throughout this Form 10-Q, including in thesection entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statementsinclude all statements that do not relate solely to historical or current facts, and can generally be identified by the use of words such as“may,” “believe,” “will,” “expect,” “intend,” “predict,” “potential,” “project,” “estimate,” “anticipate,” “plan,” or “continue” and similarexpressions, among others. The matters discussed in these forward-looking statements are based on the current plans and expectations ofour management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected,anticipated or implied in the forward-looking statements. These factors include, but are not limited to: •general economic conditions, particularly in the United States;•weakening of economic conditions that could adversely affect the level of demand for our products;•pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for ourproducts;•fluctuations in global equity and fixed-income markets;•our ability to successfully execute on or achieve the expected benefits of our restructuring initiatives;•supply chain issues and inflationary pressures;•a resurgence of the COVID-19 pandemic;•changes in the competitive environment;•t